跳至主要内容
临床试验/NCT00472563
NCT00472563已完成2 期

Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate

Universidad de Antioquia2 个研究点 分布在 1 个国家目标入组 212 人开始时间: 2007年5月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
212
试验地点
2
主要终点
development of contrast induced nephropathy, defined as an increase in serum creatinine of 25% or more within 48 h after administration of contrast

研究概览

简要总结

Deterioration of kidney renal function occurs in a minority of people due to contrast-required procedures. The purpose of this study is to compare two different interventions to reduce the risk of kidney injury after contrast medium exposition.

We will perform a randomized clinical trial following a modification of a previously published protocol (Merten et al.JAMA 2004;291(19):2328-34). Patients will be randomly assigned to one of two groups of treatment. Group A will receive 1 cc/kg/hour of 0.9% saline infusion starting 12 hours before and continuing 12 hours after the procedure. Group B will receive 3 cc/kg of sodium bicarbonate solution for one hour prior to procedure, then drip rate will be decreased to 1 cc/kg/hour until 6 hours post procedure.

详细描述

We will perform a randomized clinical trial following a modification of a previously published protocol (Merten et al.JAMA 2004;291(19):2328-34). Patients will be randomly assigned to one of two groups of treatment. Group A will receive 1 cc/kg/hour of 0.9% saline infusion starting 12 hours before and continuing 12 hours after the procedure. Group B will receive 3 cc/kg of sodium bicarbonate solution for one hour prior to procedure, then drip rate will be decreased to 1 cc/kg/hour until 6 hours post procedure.

Phase 2/3 study Study Type: Interventional Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study.

Subjects: Consecutive samples of all inpatients who meet the inclusion criteria

Primary outcomes: Development of contrast induced nephropathy, defined as an increase in serum creatinine of 25% or more within 48 h after administration of contrast.

Secondary outcomes: change in serum bicarbonate; change in serum potassium; change in serum creatinine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18+ years of age
  • Inpatient at Hospital Universitario San Vicente de Paúl scheduled to undergo diagnostic CT scan using contrast or angiography and either
  • Serum creatinine 1.2 mg/dl or more, or
  • Type 2 Diabetes Mellitus

排除标准

  • Current clinical diagnosis of exacerbated congestive heart failure
  • Exposure to contrast 30 days prior to study
  • Allergy to contrast dye
  • Chronic renal disease with dialysis therapy
  • Acute renal failure with dialytic urgency
  • Urgency procedure needed
  • Systolic blood pressure < 90 or vasopressor support
  • No authorization by patient or physician in charge
  • Serum potassium < 3 mEq/L
  • Ejection fraction < 35% by previous echocardiography
  • Acute pulmonary edema in previous 48 hours

结局指标

主要结局

development of contrast induced nephropathy, defined as an increase in serum creatinine of 25% or more within 48 h after administration of contrast

时间窗: 48 h

次要结局

  • change in serum bicarbonate; change in serum potassium; change in serum creatinine(48 h)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验